What weight loss treatment options do geriatric patients with overweight and obesity want to consider?

Abstract

INTRODUCTION Since the 1990s, a number of weight loss medications have been removed from the USA and or European market because of adverse events associated with these medications. These medications include fenfluramine (heart valve thickening), sibutramine (cardiovascular risk) and rimonabant (depression). This history may affect a patient's desire to… (More)
DOI: 10.1002/osp4.66

Topics

3 Figures and Tables